MORE►
David Halbert
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]
Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation
by Quincy Preston and David Seeley | Jun 18, 2025
The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.
by Lance Murray |
Apr 8, 2025
With the new funding, Caris said it has raised $1.86 billion in capital since 2018. Caris will use the raise to bring its science and technologies "to as many patients as possible and further our goal of revolutionizing precision medicine," Founder and CEO David Halbert said.
MORE►
